The agency is currently reviewing the SD Biosensor Pilot COVID-19 At-Home Tests recall and classifying the recall risk. The FDA is also working with SD Biosensor Inc. to assess the company's corrective actions to address the reason for bacterial contamination and to help ensure that the situation is resolved and does not happen again.